Abstract
Here, we provide an extensive overview of all reported COVID-19 cases in multiple sclerosis (MS) patients in the Netherlands between 27 February and 9 June 2020, gathered by the Dutch MS Taskforce of the Netherlands Society of Neurology. A total of 86 MS patients were reported, 43 of whom tested positive for COVID-19. Of 43 patients who tested positive, 22 patients were hospitalized. Three intensive care unit (ICU) admissions and four deaths were reported. Our findings show no apparent difference in disease-modifying treatment (DMT) use and COVID-19 disease course in Dutch MS patients. In addition, a clear link between low lymphocyte count and severe disease was not observed.
Original language | English |
---|---|
Pages (from-to) | 1256-1260 |
Number of pages | 5 |
Journal | Multiple Sclerosis Journal |
Volume | 26 |
Issue number | 10 |
DOIs | |
Publication status | Published - 1 Sep 2020 |